Practical updates in medical therapy for advanced and metastatic renal cell carcinoma

Practical updates in medical therapy for advanced and metastatic renal cell carcinoma

The evolution of therapy for advanced or metastatic renal cell carcinoma (RCC) progressed over the past decade from using cytokine immunotherapy to targeted therapy which predominantly inhibits angiogenesis via the vascular endothelial growth factor (VEGF) and mammalian target of rapamycin (mTOR) pa...

Full description

Bibliographic Details
Main Authors: Ning Yi Yap, Wan Thien Khoo, Komathi Perumal, Kar Aik Ng, Retnagowri Rajandram, Adlinda Alip, Marniza Saad, Teng Aik Ong
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Urological Science
Subjects:
Metastatic
renal cell carcinoma
targeted therapy
Online Access:http://www.e-urol-sci.com/article.asp?issn=1879-5226;year=2018;volume=29;issue=3;spage=120;epage=128;aulast=Yap

Internet

http://www.e-urol-sci.com/article.asp?issn=1879-5226;year=2018;volume=29;issue=3;spage=120;epage=128;aulast=Yap

Similar Items